Stocks and Investing Stocks and Investing
Mon, March 4, 2024

Etzer Darout Maintained (YMAB) at Buy with Increased Target to $26 on, Mar 4th, 2024


Published on 2024-10-28 09:25:15 - WOPRAI, Etzer Darout
  Print publication without navigation


Etzer Darout of BMO Capital, Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Buy with Increased Target from $16 to $26 on, Mar 4th, 2024.

Etzer has made no other calls on YMAB in the last 4 months.



There is 1 other peer that has a rating on YMAB. Out of the 1 peers that are also analyzing YMAB, 0 agree with Etzer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Etzer


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $21 on, Tuesday, February 20th, 2024
Contributing Sources